Radial artery spasm occurs frequently during the transradial approach for coronary catheterization. Premedications with nitroglycerin and verapamil have been documented to be effective in preventing radial spasms. Verapamil is relatively contraindicated for some patients with left ventricular dysfunction, hypotension and bradycardia. We would like to know whether nitroglycerin alone is sufficient for the prevention of radial artery spasm. We conducted a randomized controlled trial to compare the spasmolytic effect between heparin alone, heparin plus nitroglycerin and heparin plus nitroglycerin and varapamil during transradial cardiac catheterization. In this study, a total of 406 patients underwent transradial cardiac catheterization and intervention. After successful cannulation and sheath insertion of radial arteries, 133 patients in group A received 3,000 units of heparin, 100 µg of nitroglycerin and 1.25 mg of verapamil via sheath, 135 patients in group B received 3,000 units of heparin and 100 µg of nitroglycerin, and 93 patients in group C received 3,000 units of heparin. Five patients in group A (3.8%), 6 patients in group B (4.4%) and 19 patients in group C (20.4%) showed radial spasms. There is no statistically significant difference between groups A and B (p = 0.804), but there are strong statistically significant differences between groups A and C (p = 0.001) and groups B and C (p = 0.003). Intra-arterial premedication with 100 µg nitroglycerin and 3,000 units of heparin is effective in preventing radial spasms during transradial cardiac catheterization.

1.
Campeau L: Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989;16:3–7.
2.
Spaulding C, Lefevre T, Funck F, Thebault B, Chauveau M, Hamda KB, Chalet Y, Monsegu J, Tsocanakis O, Py A, Guillard N, Weber S: Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn 1996;39:365–370.
3.
Ludman PF, Stephens NG, Harcombe A, Lowe MD, Shapiro LM, Schofield M, Petch MC: Radial versus femoral approach for diagnostic coronary angiography in stable angina pectoris. Am J Cardiol 1997;79:1239–1241.
4.
Stella PR, Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R: Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn 1997;40:156–158.
5.
Kiemenij F, Laarman GJ, Melker ED: Transradial artery coronary angioplasty. Am Heart J 1995;129:1–7.
6.
Cowling MG, Buckenham TM, Belli AM: The role of transradial diagnostic angiography. Cardiovasc Intervent Radiol 1997;20:103–106.
7.
Wu CJ, Lo PH, Chang KC, Fu M, Lau KW, Hung JS: Transradial coronary angiography and angioplasty in Chinese patients. Cathet Cardiovasc Diagn 1997;40:159–163.
8.
Cooper CJ, El-Shiekh R, Cohen DJ, Blaesing L, Burket MW, Basu A, Moore JA: Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J 1999;138:430–436.
9.
Caputo RP, Simons A, Giambartolomei A, Grant W, Fedele K, Abraham S, Felice P, Reger MJ, Walford GD, Esente P: Safety and efficacy of repeat transradial access for cardiac catheterization procedures. Cathet Cardiovasc Diagn 2001;54:188–190.
10.
Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R: A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269–1275.
11.
Kiemeneij F, Laarman GJ, Slagboom T, van der Wieken R: Outpatient coronary stent implantation. J Am Coll Cardiol 1997;29:323–327.
12.
Goldberg SL, Renslo R, Sinow R, French WJ: Learning curve in the use of the radial artery as vascular access in the performance of percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1998;44:147–152.
13.
Hildick-Smith DJR, Lowe MD, Walsh JT, Ludman PF, Stephens NG, Schofield PM, Stone DL, Shapiro LM, Petch MC: Coronary angiography from the radial artery – Experience, complications and limitations. Int J Cardiol 1998;64:231–239.
14.
Kiemeneij F, Vajifdar BU, Eccleshall SC, Laarman G, Slagboom T, van der Wieken R: Evaluation of a spasmolytic cocktail to prevent radial artery spasm during coronary procedures. Catheter Cardiovasc Interv 2003;58:281–284.
15.
Kiemeneij F, Vajifdar BU, Eccleshall SC, Laarman G, Slagboom T, van der Wieken R: Measurement of radial artery spasm using an automatic pullback device. Catheter Cardiovasc Interv 2001;54:437–441.
16.
Clark DA: Coronary angiography by the left radial approach: a limited but useful technique. Cathet Cardiovasc Diagn 1996;39:371.
17.
He GW, Yang CQ: Comparison among arterial grafts and coronary artery: an attempt at functional classification. J Thorac Cardiovasc Surg 1995;109:707–715.
18.
He GW, Yang CQ: Characteristics of adrenoceptors in the human radial artery: clinical implications. J Thorac Cardiovasc Surg 1998;115:1136–1141.
19.
Dery JP, Simard S, Barbeau G: Reduction of discomfort at sheath remove during transradial coronary procedures with the use of hydrophylic-coated sheath. Catheter Cardiovasc Interv 2001;54:289–294.
20.
He GW: Verapamil plus nitroglycerin solution maximally preserved endothelial function of the radial artery: comparison with papaverine solution. J Thorac Cardiovasc Surg 1998;115:1321–1327.
21.
Ignarro LJ, Kadowitz PJ: The pharmacological and physiological role of cyclic CMP in vascular smooth muscle relaxation. Ann Rev Pharmacol Toxicol 1985;25:171–191.
22.
Canver CC, Armstrong VM, Cooler SD, Nichols RD: Assessment of internal thoracic artery vasoreactivity in response to sublingual nitroglycerin. Ann Thorac Surg 1997;63:1041–1043.
23.
He GW, Yang CQ: Comparative study on calcium channel antagonists in the human radial artery: clinical implications. J Thorac Cardiovasc Surg 2000;119:94–100.
24.
Shapira OM, Xu A, Vita JA, Aldea GS, Shah N, Shemin RJ, Keaney JF: Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator. J Thorac Cardiovasc Surg 1999;117:906–911.
25.
Cable DG, Caccitolo JA, Pearson PJ, et al: New approaches to prevention and treatment of radial artery graft vasospasm. Circulation 1998;98(suppl):II15–II22.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.